16 Stocks Moving in Tuesday's Pre-Market Session
Gainers Helbiz, Inc. (NASDAQ: HLBZ) shares rose 38% to $1.27 in pre-market trading following a Form 4 filing showing the purchase of 2,044,676 shares by CEO Salvatore Palella at an average price of $0.99.
Benzinga · 06/07/2022 10:09
52 Stocks Moving In Monday's Mid-Day Session
Gainers DiDi Global Inc. (NYSE: DIDI) jumped 51.4% to $2.80 after the Chinese government said the company can resume adding new users.
Benzinga · 06/06/2022 16:11
69 Biggest Movers From Friday
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.
Benzinga · 06/06/2022 09:31
ADAP, SLDP and ZSAN among mid-day movers
Gainers: Turning Point Therapeutics (TPTX) +117%. Energy Focus (EFOI) +40%. Galecto (GLTO) +25%. Adaptimmune (ADAP) +22%. Amylyx Pharmaceuticals (AMLX) +22%. AudioEye (AEYE) +20%. Sprague Resources LP (SRLP) +20%. Global Cord
Seekingalpha · 06/03/2022 16:42
40 Stocks Moving In Friday's Mid-Day Session
 Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.
Benzinga · 06/03/2022 16:07
BRIEF-Zosano Pharma Corp- On June 2 Co Got Notice From Nasdaq Indicating That Co’S Securities Will Be Delisted From Nasdaq · 06/03/2022 12:17
Why Zosano Pharma Shares Are Getting Hammered Today
Zosano Pharma Corp (NASDAQ: ZSAN) shares are trading lower by 44.35% at $0.98 after the company announced it filed a voluntary petition for relief under chapter 11.
Benzinga · 06/02/2022 18:42
Mid-Afternoon Market Update: Dow Surges Over 200 Points; Immunic Shares Slide
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Thursday.
Benzinga · 06/02/2022 18:30
LLNW and SEV among mid-day movers
Gainers: Repare Therapeutics (RPTX) +43%. Redbox Entertainment (RDBX) +33%. Avaya Holdings (AVYA) +30%. Immix Biopharma (MMX) +28%. American Superconductor Corporation (AMSC) +25%. Yumanity Therapeutics (YMTX) +24%. Chewy (CHWY) +21%. Sono Group (SEV) +21%...
Seekingalpha · 06/02/2022 16:45
Mid-Day Market Update: U.S. Stocks Turn Positive; Nasdaq Jumps 150 Points
U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining 150 points on Thursday.
Benzinga · 06/02/2022 16:20
53 Stocks Moving In Thursday's Mid-Day Session
Benzinga · 06/02/2022 16:18
East Bay migraine patch developer files for bankruptcy
With its microneedle-delivery of a generic migraine drug stalled, the company has filed for Chapter 11 bankruptcy protection.
American City Business Journals · 06/02/2022 14:15
Immix, Bright Green top healthcare gainers; while Zosano, Immunic lead losers' pack
Gainers: Immix Biopharma (IMMX) +37%. Bright Green (BGXX) +29%. Repare Therapeutics (RPTX) +29%. Yumanity Therapeutics (YMTX) +24%. PDS Biotechnology (PDSB) +15%. Losers: Zosano Pharma (ZSAN) -48%. Immunic (IMUX) -41%. Aeglea BioTherapeutics (AGLE) -40%. C...
Seekingalpha · 06/02/2022 14:00
Migraine Patch Developer Zosano Goes Bankrupt, Will Sell Assets
Bloomberg · 06/02/2022 13:45
Zosano Pharma files for Chapter 11 bankruptcy protection; shares plummet 46%
Zosano Pharma (NASDAQ:ZSAN) has filed a petition for relief under Chapter 11 bankruptcy protection. Shares are down 46% in premarket trading Zosano (ZSAN) is continuing to operate as a "debtor-in-possession" under the
Seekingalpha · 06/02/2022 12:47
Zosano Pharma Files Voluntary Petition For Relief Under Chapter 11
Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that on June 1, 2022 it filed a voluntary petition for relief under chapter 11 of title 11 (“Chapter
Benzinga · 06/02/2022 12:06
24 Stocks Moving in Thursday's Pre-Market Session
Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) rose 42.2% to $2.63 in pre-market trading after declining around 14% on Wednesday. Immix Biopharma, last month, announced positive interim data from an animal study in Soft Tissue Sarcoma (STS).
Benzinga · 06/02/2022 10:55
Five Narrow Lane Made a Big Bet on Vinco Ventures (BBIG) Stock
Investor Place · 05/27/2022 20:58
BRIEF-Emergex Vaccines Announces Successful Coating Of Its COVID-19 Vaccine Onto Zosano Pharma's Micro-Needle Patch · 05/17/2022 11:16
Zosano Pharma: Q1 Earnings Insights
Zosano Pharma (NASDAQ:ZSAN) reported its Q1 earnings results on Friday, May 13, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Zosano Pharma reported in-line EPS of $-1.75 versus an estimate of $-1.75.
Benzinga · 05/13/2022 21:26
Webull provides a variety of real-time ZSANQ stock news. You can receive the latest news about Zosano Pharma Corp through multiple platforms. This information may help you make smarter investment decisions.
Zosano Pharma Corporation is a clinical-stage biopharmaceutical company. The Company is focused on providing systemic administration of therapeutics to patients using its ransdermal microneedle system (the System). The System is designed to facilitate drug absorption into the bloodstream. The Company’s lead product candidate is Qtrypta (M207). Qtrypta is a formulation of zolmitriptan delivered utilizing its System. Zolmitriptan is a serotonin receptor agonists known as triptans and is used as an acute treatment for migraine. Qtrypta is designed for absorption of zolmitriptan into the bloodstream without dependence on the gastrointestinal (GI) tract. Its same formulation, development name C213, is the treatment to provide relief for cluster headache.